UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043964
Receipt number R000050212
Scientific Title Development of a new exercise therapy for short-term effect in hemodialysis patients with diabetic nephropathy
Date of disclosure of the study information 2021/05/01
Last modified on 2023/01/17 08:25:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a new exercise therapy for short-term effect in hemodialysis patients with diabetic nephropathy

Acronym

Development of a new exercise therapy for short-term effect in hemodialysis patients with diabetic nephropathy

Scientific Title

Development of a new exercise therapy for short-term effect in hemodialysis patients with diabetic nephropathy

Scientific Title:Acronym

Development of a new exercise therapy for short-term effect in hemodialysis patients with diabetic nephropathy

Region

Japan


Condition

Condition

Diabetic nephropathy

Classification by specialty

Endocrinology and Metabolism Nephrology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. Comparison of toe pinch force between hemodialysis patients with diabetic nephropathy and healthy subjects.
2. To examine the effectiveness of short-term toe resistance training.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change in toe pinch force

Key secondary outcomes

Exercise persistence rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Aerobic exercise
Toe resistance training

Interventions/Control_2

Aerobic exercise

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Diabetic nephropathy patients who gave consent for this study

Key exclusion criteria

1. Patients having acute metabolic disorders.
2. Patients with acute or chronic bone and joint disease, and cerebral vascular disease.
3. Patients having foot/toe deformity, and edema of the foot.
4. Patients whose daily activities are highly restricted.
5. Patients who seem inappropriate for this study by investigations.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Kataoka

Organization

Okayama Healthcare Professional University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

700-0913

Address

3-2-18, Daiku, Kitaku, Okayama 700-0913, Japan

TEL

086-233-8020

Email

h.kataoka59@gmail.com


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Kataoka

Organization

Okayama Healthcare Professional University

Division name

Department of Physical Therapy, Faculty of Health Sciences

Zip code

700-0913

Address

3-2-18, Daiku, Kitaku, Okayama 700-0913, Japan

TEL

086-233-8020

Homepage URL


Email

h.kataoka59@gmail.com


Sponsor or person

Institute

Okayama Healthcare Professional University

Institute

Department

Personal name



Funding Source

Organization

Japan Association for Diabetes Education and Care

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Review Committee, Okayama Healthcare Professional University

Address

3-2-18, Daiku, Kitaku, Okayama 700-0913, Japan

Tel

086-233-8020

Email

somu@opu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

KKR高松病院、おさふねクリニック、小畑醫院


Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 01 Day

Date of IRB

2021 Year 05 Month 12 Day

Anticipated trial start date

2021 Year 05 Month 10 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry

2022 Year 06 Month 15 Day

Date trial data considered complete

2022 Year 07 Month 30 Day

Date analysis concluded

2022 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2021 Year 04 Month 19 Day

Last modified on

2023 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050212


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name